The Hyderabad-based drug major is investing around Rs 275 crore on the facility which would be utilised to produce vaccines for the treatment of various viral diseases including COVID-19.
from Top Business News- News18.com
Read The Rest:timesnownews...
from Top Business News- News18.com
Read The Rest:timesnownews...
Aurobindo Pharma Expects to Commercialise Vaccine Facility by April-May 2021
Reviewed by Team Exprssnews
on
November 29, 2020
Rating:
No comments: